---
title: 'Effects of triple therapy on disease burden in patients of GOLD groups C and
  D: results from the observational COPD cohort COSYCONET'
date: '2024-02-29'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38424530/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240301170524&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: 'CONCLUSION: Without statistical adjustment, patients with triple therapy
  showed multiple impairments as well as elevated treatment costs. After adjusting
  for differences between treatment groups, differences were reduced. These findings
  are compatible with beneficial effects of triple therapy under continuous, long-term
  treatment, but also demonstrate the limitations encountered in the comparison of
  controlled intervention studies with observational studies in patients with severe
  COPD ...'
disable_comments: true
---
CONCLUSION: Without statistical adjustment, patients with triple therapy showed multiple impairments as well as elevated treatment costs. After adjusting for differences between treatment groups, differences were reduced. These findings are compatible with beneficial effects of triple therapy under continuous, long-term treatment, but also demonstrate the limitations encountered in the comparison of controlled intervention studies with observational studies in patients with severe COPD ...